China News Online, October 16 (Chen Jing, Xu Yu, Wang Guangzhao) Melanoma, which is often shown as "malignant moles", is a highly malignant tumor. For various reasons, the 5-year survival rate of Chinese melanoma patients not tall.
The Melanoma Special Committee of Shanghai Anti-Cancer Association was formally established on the 16th to create a comprehensive treatment team integrating tumor surgery, plastic surgery, biotherapy, pathology and other disciplines to consolidate the joint melanoma treatment and crack the current Chinese melanin Difficulties in tumor diagnosis and treatment have improved the quality of life of melanoma patients.
The Melanoma Special Committee of the Shanghai Anti-Cancer Association was established to create a comprehensive treatment team integrating tumor surgery, plastic surgery, biotherapy, pathology and other disciplines.
Photo courtesy of Fudan University Cancer Hospital
Professor Chen Yong, director of the Malignant Melanoma Diagnosis and Treatment Center (referred to as the Diagnosis and Treatment Center) of Fudan University Affiliated Tumor Hospital, served as the chairman of the first special committee.
In an interview that day, Chen Yong said: The scattered admissions departments, the differences in treatment strategies of different experts, and the lack of integrated and unified diagnosis and treatment standards and consensus are important reasons for the high mortality of melanoma.
Chen Yong told reporters: "Chinese melanoma cases have unique characteristics, which are quite different from European and American white races: In European and American countries, nearly 90% of melanoma patients are skin type; while 60% of Chinese melanoma patients are acral. Type, and a considerable proportion of cases are mucosal type."
In early 2020, the "Chinese Expert Consensus on the Diagnosis and Treatment of Skin and Acral Malignant Melanoma" jointly led by Fudan University Cancer Hospital, Tianjin Cancer Hospital, and Chinese Academy of Sciences Cancer Hospital was officially released in Shanghai.
There are "rules to follow" in the diagnosis and treatment of malignant melanoma in China.
It is reported that the diagnosis and treatment center is committed to promoting early diagnosis and comprehensive diagnosis and treatment of melanoma.
Chen Yong said frankly: "At present, the treatment of melanoma has entered the era of precision treatment, and the treatment model suitable for the subtypes of melanoma in China has gradually formed corresponding norms, but the promotion still has a long way to go." It is reported that well-known experts from many hospitals here will serve as special committees. The vice chairman and secretary-general of the meeting; the standing committee, members and youth committee members of the special committee will be composed of expert physicians who are keen on melanoma diagnosis and treatment in different departments of major hospitals in Shanghai.
According to reports, the diagnosis and treatment center is working with many medical centers in China to try to create a single disease database.
The database adds more than 1,000 surgical treatment data and 700 medical treatment data every year.
Chen Yong hopes to integrate patient diagnosis and treatment follow-up information through the establishment of a database to realize the full-process management of patients; at the same time, summarize the treatment experience so that scientific research results can be transformed into clinical applications.
During the interview, the reporter learned that the Malignant Melanoma Diagnosis and Treatment Center of Fudan University Cancer Hospital has also successively established cooperative relationships with many well-known hospitals in the United States and the United Kingdom, and conducted dozens of clinical trials and basic research.